Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imre Noth

Showing results (141-150 of 211) with videos related to

Pageof 22
Sort By:
Biorxiv : the Preprint Server for Biology|May 10, 2023
PhIP-Seq uncovers novel autoantibodies and unique endotypes in interstitial lung diseaseVaibhav Upadhyay, Young Me Yoon, Sara E Vazquez, et al.
American Journal of Respiratory and Critical Care Medicine|September 15, 2018
Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent ValidationAyodeji Adegunsoye, Justin M Oldham, Catherine Bonham, et al.
American Journal of Respiratory and Critical Care Medicine|February 29, 2024
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung DiseaseYong Huang, Shwu-Fan Ma, Justin M Oldham, et al.
Thorax|August 20, 2015
Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis: role of S1P signalling and autophagyLong Shuang Huang, Evgeny V Berdyshev, John T Tran, et al.
Respiratory Research|June 21, 2023
Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progressionPeifeng Ruan, Jamie L Todd, Hongyu Zhao, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 2026
Opportunities for Human Lung Tissue-Based Studies in Fibrotic ILD ResearchJeffrey M Sturek, John S Kim, Anna Podolanczuk, et al.
Chest|November 5, 2017
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary FibrosisIvan O Rosas, Hilary J Goldberg, Harold R Collard, et al.
ACR Open Rheumatology|July 2, 2024
Phage Immunoprecipitation-Sequencing Reveals CDHR5 Autoantibodies in Select Patients With Interstitial Lung DiseaseVaibhav Upadhyay, Young Me Yoon, Sara E Vazquez, et al.
Science Translational Medicine|October 4, 2013
Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosisJose D Herazo-Maya, Imre Noth, Steven R Duncan, et al.
Respiratory Research|March 14, 2020
Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trialKevin J Anstrom, Imre Noth, Kevin R Flaherty, et al.
Pageof 22

Showing results (141-150 of 211) with videos related to

Sort By:
Pageof 22
Biorxiv : the Preprint Server for Biology|May 10, 2023
PhIP-Seq uncovers novel autoantibodies and unique endotypes in interstitial lung diseaseVaibhav Upadhyay, Young Me Yoon, Sara E Vazquez, et al.
American Journal of Respiratory and Critical Care Medicine|September 15, 2018
Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent ValidationAyodeji Adegunsoye, Justin M Oldham, Catherine Bonham, et al.
American Journal of Respiratory and Critical Care Medicine|February 29, 2024
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung DiseaseYong Huang, Shwu-Fan Ma, Justin M Oldham, et al.
Thorax|August 20, 2015
Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis: role of S1P signalling and autophagyLong Shuang Huang, Evgeny V Berdyshev, John T Tran, et al.
Respiratory Research|June 21, 2023
Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progressionPeifeng Ruan, Jamie L Todd, Hongyu Zhao, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 2026
Opportunities for Human Lung Tissue-Based Studies in Fibrotic ILD ResearchJeffrey M Sturek, John S Kim, Anna Podolanczuk, et al.
Chest|November 5, 2017
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary FibrosisIvan O Rosas, Hilary J Goldberg, Harold R Collard, et al.
ACR Open Rheumatology|July 2, 2024
Phage Immunoprecipitation-Sequencing Reveals CDHR5 Autoantibodies in Select Patients With Interstitial Lung DiseaseVaibhav Upadhyay, Young Me Yoon, Sara E Vazquez, et al.
Science Translational Medicine|October 4, 2013
Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosisJose D Herazo-Maya, Imre Noth, Steven R Duncan, et al.
Respiratory Research|March 14, 2020
Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trialKevin J Anstrom, Imre Noth, Kevin R Flaherty, et al.
Pageof 22